David Dullum
Analyst · Ladenburg Thalmann. Your line is now open
Great. Thanks, Mike, and good morning, everyone. Just reflecting on the last report, which we gave not all that many months ago for our fiscal year-end March, and it seems like it's been quite a long time in part because obviously with everything going on with COVID, and we've all had to deal with in lots of different ways. In our case, Gladstone Investment as we go through this, I'll hopefully leave you all with a sense that one we, which, you all know, we came off of actually probably one of our best years in fiscal 2020 ending March 20. So that helped us with a good head of steam going into this fiscal year. But of course, we've all have to deal with the reality of where we've been. And so we'll touch on that and let you know what we're doing to ensure that our company keeps doing all the right things going forward and getting through this. And as a result of that, we didn't know what to expect obviously right in the beginning of going into COVID. As it turned out, we were able to end the quarter at June 30 and with reporting adjusted net investment income of $0.11 per share. And while this was against $0.19 per share for the quarter ended 3/20 -- 3/31 sorry, and we'll explain a bit more about that. We feel pretty good about that under the circumstances, and more importantly, as we move through the year, where we're headed. On a comparative basis, actually the total portfolio income which is primarily interest income on our debt investments was actually relatively stable quarter-to-quarter which is a good thing and is a testament to the foundation of the assets that we own both the debt and the equity. I really think that's important to understand and we'll hear more about that going forward. So just keep that in mind. Our primary operating focus obviously has been since we got into this and continues to be clearly closely monitoring our portfolio companies. The emphasis is on the cash flow and the working capital dynamic, if you will, of each of our portfolio companies. It really is important in this time to stress that and we keep working with our companies to get through that. Most of our companies happily I can say have performed pretty well, including some of them which have actually exceeded our expectations when we were going into this. So those where we've had some drop-off or decline really are all a function clearly of the COVID activity and what's going on in the economy in general, and frankly, not so much around the underlying operations of those companies. To-date, as a result of that, we've not necessarily needed to provide very much additional financial support, which is a good thing. But even if we needed to, and if we did, we do have sufficient liquidity for that purpose. As I mentioned, obviously in our fiscal year-end report back a number of months ago, we had exited a few of our portfolio companies last year, which generated very significant liquidity for us through the net realized capital gains and obviously the repayment of our debt securities. So we ended a really strong, again the year last year, not just the calendar 2019, but also our fiscal year, March 2020, and that's put us in good position to support our portfolio companies going forward. We also are able and will continue to grow and rebuild the portfolio. And in this regard, in July, it was just after our quarter end at 6/30, we actually did make a new buyout investment for about $47 million, which was a combination of equity and debt. And obviously, that $47 million a pretty significant part of that is the debt security, which is a good thing because that does generate obviously interest income for us. Our NAV, which is book value, for the 6/30 period was $10.87 per share and that compares to $11.17 at the 3/31/20 quarter-end, so a decrease of $0.30 per share. But again, that was a result in part obviously of some of our companies that were affected and some more than others by a decline, obviously initially in operating earnings, and as we valued them, they had to come down in value fundamentally, as a result, actually of the COVID activity and not underlying operating. We had a number of our companies that are really good businesses that were in sectors that were directly impacted by COVID and obviously their earnings were off relatively speaking and that's reflected in these valuations. This was again the NAV for 6/30 compared to what it was at 3/31/20. So in terms of the pandemic and the actions that we have taken, just follow-on the report that we gave our actions early on, we were continuing to actively monitor the potential issues in the portfolio. We're proactively engaged with their management teams to providing the support as necessary. Our Managing Directors, our team who work very closely with each portfolio company, and we're focused on things such as re-forecasting the potential for temporary capital needs that any of these companies might have. Obviously, there's a fair amount of stuff that goes into the legal resources, if you will, around HR-related in great part because people are coming back to work. And each company has to be responsible for employees and being sure that we're doing all the right things. So the good news there is we are seeing activity with companies and people coming back to work. And again, we've not had to provide at this point, much support, either through additional investments or really accommodation on interest obligations, and that's something we're going to keep striving for, and working very hard on. The aggregate portfolio values from 12/31/19 to 3/31/20 depreciated about 8%, which I mentioned before, and that was primarily again, due to the effect of the pandemic, obviously affecting not only the operations of portfolio companies, but market multiples. But to this quarter again fortunately, we've seen stabilization in these values. And we had essentially only about a 1% decline in fair values from the 3/31 quarter to the 6/30 quarter. So I'm really encouraged by that. And obviously, we're seeing some companies that are slightly more affected than others, again, based on their sector, and also the geographic location of those companies. So depending on the duration of the pandemic and the timing of an economic recovery, it is possible you might experience a bit further individual portfolio company devaluation, same time we might see as well improvement in other, so this is a balancing act, obviously. And again, I want to reemphasize that we work with our companies very carefully and that's why in times like these as we keep saying, the type of our approach being an equity and debt provider and majority owner of most of these companies that really provides us this advantage, that gives us a lot more flexibility whether we have to financially do some structuring to help with a cash flow management of the companies in the portfolio, preservation of value, and so on. And we'll talk a bit more about companies that are on non-accrual, we've only had one that has to go on non-accrual as a function of really COVID activity. And you will hear a little bit more about that. But I want to again, leave us with the thought that those that are on non-accrual are good companies, we continue working, we've made some progress with them, and we expect and hope to see some of them as we go through the yesteryears come back off of non-accrual. So that's what we're working on. In terms of our outlook in general, our focus obviously is continuing just close involvement with the portfolio companies. We also actively continue to review potential new acquisitions. The challenge obviously continues to be how you pursue quality due diligence and determine as I would say, the rationale views on what the right purchase value may be and obviously our expected returns, we're going to maintain and stick with our philosophy of the kinds of returns that we look for. And this might give us an opportunity as the markets we're seeing having a tendency to come back to some rationalization in valuations and that that's a good thing for us. Obviously, we're trying to conduct a bulk of this activity on due diligence in what is now become as would call it a Zoom type environment. That's an interesting experience. But we're doing that and actually, the new acquisition we made right in the beginning of July, we were able to get that closed by effectively using this Zoom capability. So that's where we're going. We're seeing some pickup in deal flow and we keep working on that part beyond just the one of preservation of our existing portfolio. All in all, I think it's in a really good position and we just have to be a little patient as we pull-through over the next nine months. So I'm going to stop there and turn it over to Julia Ryan, our CFO. Julia?